Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 357

1.

Bisphosphonates: a therapeutic option for knee osteoarthritis?

Lems WF.

Ann Rheum Dis. 2017 Dec 13. pii: annrheumdis-2017-212364. doi: 10.1136/annrheumdis-2017-212364. [Epub ahead of print] No abstract available.

PMID:
29237617
2.

Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.

Lems WF, Raterman HG.

Ther Adv Musculoskelet Dis. 2017 Dec;9(12):299-316. doi: 10.1177/1759720X17732562. Epub 2017 Oct 27. Review.

3.

The immediate effect of a soft knee brace on pain, activity limitations, self-reported knee instability, and self-reported knee confidence in patients with knee osteoarthritis.

Cudejko T, van der Esch M, van der Leeden M, van den Noort JC, Roorda LD, Lems W, Twisk J, Steultjens M, Woodburn J, Harlaar J, Dekker J.

Arthritis Res Ther. 2017 Dec 1;19(1):260. doi: 10.1186/s13075-017-1456-0.

4.

Factors associated with upper leg muscle strength in knee osteoarthritis: A scoping review.

de Zwart AH, Dekker J, Lems W, Roorda LD, van der Esch M, van der Leeden M.

J Rehabil Med. 2017 Nov 29. doi: 10.2340/16501977-2284. [Epub ahead of print]

5.

Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial.

Ter Wee MM, Coupé VM, den Uyl D, Blomjous BS, Kooijmans E, Kerstens PJ, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Boers M, Lems WF.

RMD Open. 2017 Oct 25;3(2):e000502. doi: 10.1136/rmdopen-2017-000502. eCollection 2017.

6.

Proprioception mediates the association between systemic inflammation and muscle weakness in patients with knee osteoarthritis: results from the Amsterdam Osteoarthritis cohort.

Cudejko T, van der Esch M, van der Leeden M, Holla J, Roorda LD, Lems W, Dekker J.

J Rehabil Med. 2017 Sep 20. doi: 10.2340/16501977-2272. [Epub ahead of print]

7.

What have we learned from BeSt?

Allaart CF, Markusse IM, Lems WF.

Clin Immunol. 2017 Sep 18. pii: S1521-6616(17)30676-9. doi: 10.1016/j.clim.2017.09.017. [Epub ahead of print]

8.

Inflammatory diseases and bone fragility.

Briot K, Geusens P, Em Bultink I, Lems WF, Roux C.

Osteoporos Int. 2017 Dec;28(12):3301-3314. doi: 10.1007/s00198-017-4189-7. Epub 2017 Sep 15. Review.

PMID:
28916915
9.

Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.

Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, van der Wijden LKM, Bultink IEM, Kerstens PJSM, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Rheumatology (Oxford). 2017 Sep 1;56(9):1586-1596. doi: 10.1093/rheumatology/kex223.

PMID:
28859326
10.

Analgesic use in patients with knee and/or hip osteoarthritis referred to an outpatient center: a cross-sectional study within the Amsterdam Osteoarthritis Cohort.

Knoop J, van Tunen J, van der Esch M, Roorda LD, Dekker J, van der Leeden M, Lems WF.

Rheumatol Int. 2017 Oct;37(10):1747-1755. doi: 10.1007/s00296-017-3785-3. Epub 2017 Aug 18.

PMID:
28821939
11.

Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.

van der Velde RY, Bours SPG, Wyers CE, Lems WF, Geusens PPMM, van den Bergh JPW.

Osteoporos Int. 2017 Oct;28(10):3017-3022. doi: 10.1007/s00198-017-4147-4. Epub 2017 Jul 26.

12.

Fat Mass Lowers the Response to Tumor Necrosis Factor-α Blockers in Patients with Ankylosing Spondylitis.

Ibáñez Vodnizza SE, Nurmohamed MT, Visman IM, van Denderen JC, Lems WF, Jaime F, van der Horst-Bruinsma IE.

J Rheumatol. 2017 Sep;44(9):1355-1361. doi: 10.3899/jrheum.170094. Epub 2017 Jul 15.

PMID:
28711878
13.

Nonlinear relationship between isokinetic muscle strength and activity limitations in patients with knee osteoarthritis: Results of the Amsterdam-Osteoarthritis cohort.

Edelaar LM, van Dieën JH, van der Esch M, Roorda LD, Dekker J, Lems WF, van der Leeden M.

J Rehabil Med. 2017 Jul 7;49(7):598-605. doi: 10.2340/16501977-2252.

14.

Muscle wasting in male TNF-α blocker naïve ankylosing spondylitis patients: a comparison of gender differences in body composition.

Ibáñez Vodnizza S, Visman IM, van Denderen C, Lems WF, Jaime F, Nurmohamed MT, van der Horst-Bruinsma IE.

Rheumatology (Oxford). 2017 Sep 1;56(9):1566-1572. doi: 10.1093/rheumatology/kex187.

PMID:
28605535
15.

Is Fragility Fracture a Strong Risk Factor for a Cardiovascular Event in Rheumatoid Arthritis? The Challenge of Dealing with Multiple Comorbidities.

Lems WF.

J Rheumatol. 2017 May;44(5):545-546. doi: 10.3899/jrheum.170202. No abstract available.

PMID:
28461515
16.

The Relationship Between Cardiac Conduction Times, Cardiovascular Risk Factors, and Inflammation in Patients with Early Arthritis.

Turk SA, Heslinga SC, Dekker J, Britsemmer L, van der Lugt V, Lems WF, van Schaardenburg D, Nurmohamed MT.

J Rheumatol. 2017 May;44(5):580-586. doi: 10.3899/jrheum.161184. Epub 2017 Apr 1.

PMID:
28365582
17.

Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review.

Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N, Reginster JY, Chapurlat R, Chan DC, Bruyère O, Rizzoli R, Cooper C, Dennison EM; IOF-ESCEO Sarcopenia Working Group.

Osteoporos Int. 2017 Jun;28(6):1817-1833. doi: 10.1007/s00198-017-3980-9. Epub 2017 Mar 1. Review.

18.

Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.

van den Oever IAM, Heslinga M, Griep EN, Griep-Wentink HRM, Schotsman R, Cambach W, Dijkmans BAC, Smulders YM, Lems WF, Boers M, Voskuyl AE, Peters MJL, van Schaardenburg D, Nurmohamed MT.

Rheumatology (Oxford). 2017 Sep 1;56(9):1472-1478. doi: 10.1093/rheumatology/kew497.

PMID:
28199724
19.

Content Validity of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis.

Rasch LA, de van der Schueren MA, van Tuyl LH, Bultink IE, de Vries JH, Lems WF.

Calcif Tissue Int. 2017 Mar;100(3):271-277. doi: 10.1007/s00223-016-0221-8. Epub 2017 Jan 12.

20.

Symptomatic unilateral sacroiliitis as a first presenting feature of IgG4-related disease with successful response to treatment after 1 year of follow-up article.

Jamnitski A, van Hall O, de Vries N, van der Valk P, Lems WF, van der Horst-Bruinsma IE.

Rheumatology (Oxford). 2017 Apr 1;56(4):670-671. doi: 10.1093/rheumatology/kew481. No abstract available.

PMID:
28039416

Supplemental Content

Loading ...
Support Center